Peace Naturals Project Receives Approval to Supply Medical Cannabis
November 13th, 2013
News, Top Story
The Peace Naturals Project, a federally licensed and regulated commercial medical Cannabis producer, has been granted a license by Health Canada to produce and distribute medical Cannabis in Canada under the new Marihuana for Medical Purposes Regulations (MMPR). The Ontario-based company is the first new producer not previously a supplier to the Federal Government, to be granted this license after achieving the rigorous security and operational requirements set forth by Health Canada.
“I am very proud that we’ve reached this milestone, which is truly transformative for thousands of Canadians striving to manage their medical conditions,” says Mark Gobuty, Founder and CEO, The Peace Naturals Project. “We are looking forward to helping make people’s lives a little bit better with safe, effective and consistent quality Agri-Health solutions.”
Medical Cannabis, also known as medical marihuana, has been used by patients with a number of serious illnesses, including multiple sclerosis, spinal cord injuries, asthma and arthritis, among others. Medical benefits include, but are not limited to: pain relief, muscle relaxation, decreased nausea and increased appetite.
The Peace Naturals Project offers a range of conventional and organic, allergen-free, harm-reducing whole Cannabis flower solutions, based on a unique assortment of proprietary medical Cannabis varieties, with varying degrees of active components to assist with different medical conditions and symptoms. The Peace Naturals Project prides itself on achieving a consistent level of quality through a strict standardization protocol and 25 years of combined research and agronomic practices. At Peace Naturals, an optimal Cannabis treatment that suits specific client needs can be selected from a number of Cannabis varieties, including those that have non psychoactive effects. To date, The Peace Naturals Project has nine varieties that are available to registered clients.
Health Canada’s licensing process is part of the Government’s plan to change the way Canadians access marihuana for medical purposes and transition to a new Marihuana for Medical Purposes Regulations regime. According to Health Canada, the current Marihuana Medical Access Regulations (MMAR) will be repealed on March 31, 2014, and, effective April 1, 2014, the new MMPR program that replaces MMAR will go into effect. Health Canada will no longer distribute marihuana for medical purposes, but will instead oversee licensing of a body of approved suppliers. The new regulations are designed to provide secure access to quality-controlled marihuana for medical purposes to those Canadians who need it. Effective October 1, 2013, the transition to MMPR began. Health Canada no longer accepts new applications for personal licences under the MMAR. New and converting medical Cannabis patients will be able to purchase their medicine through a licensed producer authorized by Health Canada.
“The Marihuana for Medical Purposes Regulations program is a long-awaited step in the right direction. While I support the government’s action, I encourage Health Canada and other stakeholders to work together to make sure the program produces the intended results,” says Professor Alan Young, Osgoode Law School. “We need to think about providing the information and resources to both patients and their support networks, on the one hand, and to healthcare practitioners, on the other, to facilitate uninterrupted, secure access to quality medical Cannabis and compassionate service delivery for those who need it. The Peace Naturals Project has a passionate team and a great infrastructure in place to pioneer best practices in the production and distribution of medicinal Cannabis under the MMPR program to raise the standards bar in the new commercial industry.”
“The Peace Naturals Project strives to be the best commercial Cannabis resource in Canada,” says Gobuty, “The principles of integrity, transparency, security and compliance are absolutely critical to this project. As more patients and healthcare practitioners embrace broader solutions to health challenges, we are well-positioned to be at the forefront of shaping a viable commercial industry, influencing attitudes, behaviours and business models as well as facilitating much-needed education and awareness around medical Cannabis as part of an overall self-care solution.”
Health Canada, which regulates the country’s medical Cannabis growing operations, anticipates more than 450,000 authorized users by 2024. The government’s approach to this treatment creates new options for patients seeking to make responsible and safe health and lifestyle choices. According to Health Canada, since the introduction of its MMAR program in 2001, the program has grown exponentially, from fewer than 500 authorized persons to more than 37,000 today.
In Canada, patients will be able to purchase an appropriate amount of medical Cannabis, based on their medical condition, directly from a commercial medical Cannabis producer licensed by Health Canada with a medical document signed by a healthcare practitioner.
The Peace Naturals Project expansion plans include a number of local community and sustainability initiatives. The company will offer job opportunities to local professionals and will mitigate its expanding energy demands through the mixed use of natural gas and electricity. It will also champion environmental sustainability and land stewardship best practices using a five-phase permaculture design plan.
About The Peace Naturals Project
The Peace Naturals Project is a federally licensed and regulated Canadian medical Cannabis producer and distributor based inOntario. The company cultivates strains of Cannabis that can be used for medicinal purposes, employing proven, proprietary plant varieties and offering a range of organic medical Cannabis solutions. The Peace Naturals Project, which has extensive experience in natural health food production and agronomy, is one of the first new commercial producers granted a license byHeath Canada to produce and distribute medical Cannabis in Canada. Its transformative patient-centric model is based on a strong understanding of the growing medical Cannabis industry, a holistic approach to living well and the principles of integrity, transparency, security, compliance, and social environmental sustainability. The Peace Naturals Project is a privately held, wholly owned Canadian company focused on becoming the global Agri-Health leader in the development of effective and safe medical Cannabis solutions.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.